InvestorsHub Logo
icon url

MedResCollab

06/20/19 1:02 PM

#197758 RE: ggwpq #197749

ggwpq,

Thanks, we’ll retract the second half of our statement on management’s silence on an AdComm, but not the first half that accurately conveys the preliminary plans for an AC from FDA in the 74-day letter.

We expect an AC.

Regards,
-MRC Team